Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 3 金草止咳口服液治疗小儿急性支气管炎(痰热壅肺证)有效性和安全性的随机、双盲、低剂量对照、多中心临床试验
[Translation] A randomized, double-blind, low-dose controlled, multicenter clinical trial on the efficacy and safety of Jincao cough-relieving oral liquid in the treatment of acute bronchitis (phlegm-heat obstructing the lungs) in children
主要目的:
评价金草止咳口服液治疗小儿急性支气管炎(痰热壅肺证)的有效性;
次要目的:
评价金草止咳口服液治疗小儿急性支气管炎(痰热壅肺证)的安全性。
[Translation] Main purpose:
To evaluate the effectiveness of Jincao cough-relieving oral liquid in treating acute bronchitis (phlegm-heat obstructing the lungs) in children;
Secondary purpose:
To evaluate the safety of Jincao cough-relieving oral liquid in treating acute bronchitis (phlegm-heat obstructing the lungs) in children.
100 Clinical Results associated with Beijing Langzhen Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Langzhen Pharmaceutical Technology Co., Ltd.
100 Deals associated with Beijing Langzhen Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Beijing Langzhen Pharmaceutical Technology Co., Ltd.